Cinclus Pharma Holding AB (publ) (STO: CINPHA)
Sweden
· Delayed Price · Currency is SEK 20.30
0.00 (0.00%)
At close: Dec 20, 2024
Cinclus Pharma Holding AB Revenue
In the year 2023, Cinclus Pharma Holding AB had annual revenue of 5.96M SEK, down -43.63%.
Revenue
5.96M
Revenue Growth
-43.63%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
944.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5.96M | -4.61M | -43.63% |
| Dec 31, 2022 | 10.57M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.14B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Vitrolife AB (publ) | 3.56B |
| Medicover AB (publ) | 22.60B |
| Bonesupport Holding AB (publ) | 814.46M |